14 mayo 2015
An international team of scientists has used a sophisticated combination of proteomics and metabolomics to show how renal cell carcinoma (RCC) reprograms its metabolism and evades the immune system. In addition, the study found that cancer grade has a major impact on this reprogramming. These results point to new therapeutic options for this particularly deadly cancer.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/b3-_Ac0gO14/150514095239.htm
